Jun Ishikawa

1.9k total citations
82 papers, 1.3k citations indexed

About

Jun Ishikawa is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Jun Ishikawa has authored 82 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 22 papers in Immunology and 21 papers in Oncology. Recurrent topics in Jun Ishikawa's work include Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (14 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Jun Ishikawa is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (14 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Jun Ishikawa collaborates with scholars based in Japan, United States and Spain. Jun Ishikawa's co-authors include Itaru Matsumura, Yuzuru Kanakura, Yoshiaki Tomiyama, Takashi Kato, Hiroya Ikeda, Kenji Oritani, H. Kitayama, Yūji Matsuzawa, A Kuriu and Y Kanakura and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Jun Ishikawa

76 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun Ishikawa Japan	19	621	358	349	319	293	82	1.3k
Akira Kitanaka Japan	23	348 0.6×	751 2.1×	465 1.3×	392 1.2×	240 0.8×	80	1.7k
Craig E. Hughes United Kingdom	24	826 1.3×	250 0.7×	223 0.6×	325 1.0×	225 0.8×	37	1.5k
Yu Hou China	22	918 1.5×	586 1.6×	195 0.6×	333 1.0×	275 0.9×	78	1.8k
Manabu Musashi Japan	14	320 0.5×	400 1.1×	266 0.8×	517 1.6×	94 0.3×	45	1.3k
Teresa Caballero‐Velázquez Spain	15	479 0.8×	279 0.8×	173 0.5×	219 0.7×	170 0.6×	53	892
Panagiotis Tsapogas Switzerland	20	311 0.5×	454 1.3×	162 0.5×	459 1.4×	115 0.4×	34	1.3k
Michal Abraham Israel	26	438 0.7×	431 1.2×	724 2.1×	975 3.1×	103 0.4×	46	1.8k
Mohammad Salem Denmark	16	332 0.5×	358 1.0×	263 0.8×	458 1.4×	58 0.2×	31	1.1k
Donald G. Morris Canada	17	426 0.7×	412 1.2×	466 1.3×	153 0.5×	150 0.5×	48	1.3k
Michael Byrne United States	17	514 0.8×	611 1.7×	280 0.8×	154 0.5×	96 0.3×	81	1.4k

Countries citing papers authored by Jun Ishikawa

Since Specialization

Citations

This map shows the geographic impact of Jun Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ishikawa more than expected).

Fields of papers citing papers by Jun Ishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ishikawa. The network helps show where Jun Ishikawa may publish in the future.

Co-authorship network of co-authors of Jun Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Ishikawa. A scholar is included among the top collaborators of Jun Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Ishikawa. Jun Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iwasaki, Makoto, Masahiro Hirayama, Koji Kawamura, et al.. (2025). Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation. Leukemia. 39(4). 951–961. 1 indexed citations

Nakamae, Hirohisa, Eisei Kondo, Takahiro Fukuda, et al.. (2024). Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma. Bone Marrow Transplantation. 59(5). 630–636. 1 indexed citations

Shimomura, Yoshimitsu, Sung‐Won Kim, Hiroyuki Ohigashi, et al.. (2024). Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation. British Journal of Haematology. 205(3). 1097–1107. 1 indexed citations

Fuji, Shigeo, et al.. (2023). Gilteritinib in peritransplant period for relapsed or refractory FLT3-mutated acute myeloid leukemia: A case report of three patients. PubMed. 6(3). 77–79. 1 indexed citations

Sugita, Junichi, Jun Ishikawa, Tetsuya Eto, et al.. (2023). Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor. Bone Marrow Transplantation. 59(3). 344–349.

Fuji, Shigeo, Junichi Sugita, Yuho Najima, et al.. (2023). Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation. British Journal of Haematology. 204(3). 959–966. 6 indexed citations

Fuji, Shigeo, et al.. (2023). A case of severe oral mucosal GVHD induced by heterologous SARS-CoV-2 vaccination after cord blood transplantation. PubMed. 6(2). 49–53. 1 indexed citations

Shiratori, Souichi, Mio Kurata, Junichi Sugita, et al.. (2021). Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation—A Matched-Pair Analysis. Transplantation and Cellular Therapy. 27(12). 995.e1–995.e6. 2 indexed citations

Kukita, Yoji, Masanori Kitamura, Masako Kurashige, et al.. (2021). Bcl‐2‐negative IGH‐BCL2 translocation‐negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl‐2‐positive IGH‐BCL2 translocation‐positive follicular lymphoma. Histopathology. 79(4). 521–532. 5 indexed citations

10.

Fuji, Shigeo, Hitoshi Yoshida, Eri Watanabe, et al.. (2020). Successful treatment strategy in corporating mogamulizumab and cord blood transplantation in aggressive adult T-cell leukemia-lymphoma: a case report. PubMed. 3(1). 6–10. 1 indexed citations

11.

Fuji, Shigeo, et al.. (2020). Clinical Outcomes of Patients with Adult T Cell Leukemia-Lymphoma in a Nonendemic Metropolitan Area: A Retrospective Analysis of the Population-Based Osaka Cancer Registry. Biology of Blood and Marrow Transplantation. 26(8). 1433–1438. 5 indexed citations

12.

Murata, Hiroko, et al.. (2020). Two cases of spindle cell variant diffuse large B-cell lymphoma of the uterine cervix. Gynecologic Oncology Reports. 33. 100611–100611. 2 indexed citations

13.

Nagafuji, Koji, Itaru Matsumura, Takayuki Shimose, et al.. (2019). Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt). International Journal of Hematology. 110(6). 675–682. 22 indexed citations

14.

Morita, Yasuyoshi, Yasuhiro Maeda, Terufumi Yamaguchi, et al.. (2018). Five‐day regimen of azacitidine for lower‐risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single‐arm phase 2 trial. Cancer Science. 109(10). 3209–3215. 10 indexed citations

15.

Yokoyama, Hisayuki, Junya Kanda, Shunichi Kato, et al.. (2018). Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation. Bone Marrow Transplantation. 54(7). 1004–1012. 14 indexed citations

16.

Ezoe, Sachiko, Itaru Matsumura, Karin B. Gale, et al.. (2005). GATA Transcription Factors Inhibit Cytokine-dependent Growth and Survival of a Hematopoietic Cell Line through the Inhibition of STAT3 Activity. Journal of Biological Chemistry. 280(13). 13163–13170. 30 indexed citations

17.

Harashima, Hiroshi, et al.. (2004). Development of i-ball 2: An Interaction Platform with a Crystal-Ball-Like Display. The Journal of The Institute of Image Information and Television Engineers. 58(6). 842–845. 1 indexed citations

18.

Matsumura, Itaru, Hirokazu Tanaka, Sachiko Ezoe, et al.. (2004). NF-κB Family Proteins Participate in Multiple Steps of Hematopoiesis through Elimination of Reactive Oxygen Species. Journal of Biological Chemistry. 279(53). 55578–55586. 36 indexed citations

19.

Okajima, Yu, Itaru Matsumura, Tetsuo Nishiura, et al.. (1998). Insulin-like Growth Factor-I Augments Erythropoietin-induced Proliferation through Enhanced Tyrosine Phosphorylation of STAT5. Journal of Biological Chemistry. 273(36). 22877–22883. 28 indexed citations

20.

Matsumura, Itaru, Jun Ishikawa, Koichi Nakajima, et al.. (1997). Thrombopoietin-Induced Differentiation of a Human Megakaryoblastic Leukemia Cell Line, CMK, Involves Transcriptional Activation of p21 ^WAF1/Cip1 by STAT5. Molecular and Cellular Biology. 17(5). 2933–2943. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact